Skip to main content
SpringerLink
Log in

Urgences hématologiques et oncologiques

  • Chapter
Précis d’hématologie et d’oncologie

  • 776 Accesses

Résumé

Déf.: Développement d’une infection (processus septique) chez un patient neutropénique (dans le contexte d’une chimiothérapie ou d’une radiothérapie)

  • • Sepsis: température > 38,0 °C ou < 36 °C, fréquence cardiaque > 90/min, fréquence respiratoire > 20/min ou PaCO2 < 32 mmHg.

  • • Choc septique: hypotension avec tension artérielle (TA) < 90 mmHg (systolique) ou réduction de TA de 40 mmHg et signes de défaillance d’organe: acidose lactique, oligurie, défaillance multiviscérale (DMV).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Réf.

  1. Aapro MS, Cameron DA, Pettengell R et al. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer 2006;42:2433–2453

    Article  PubMed  CAS  Google Scholar 

  2. Bertz H, Auner HW, Weissinger F et al. Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation: guidelines of the AGIHO/DGHO. Ann Hematol 2003;82(suppl 2):S167–174

    Article  PubMed  Google Scholar 

  3. Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences and new directions for its management. Cancer 2004;100:228–237

    Article  PubMed  Google Scholar 

  4. ESMO Guidelines Working Group. Hematopoietic growth factors: ESMO Recommendations for the application. Ann Oncol 2007;18(Suppl.2):ii89–91

    Google Scholar 

  5. Penack O, Beinert T, Buchheidt D et al. Management of sepsis in neutropenia: guidelines of the AGIHO/DGHO. Ann Hematol 2006;85:424–433

    Article  PubMed  Google Scholar 

  6. Sipsas NV, Bodey GP, Kostoyiannis DP. Perspectives for the management of febrile neutropenic patients. Cancer 2005;103:1103–1113

    Article  PubMed  Google Scholar 

  7. Smith TJ, Khatcheressian J, Lyman GJ et al. 2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline. J Clin Oncol 2006;24:3187–3205

    Article  PubMed  CAS  Google Scholar 

Réf.

  1. Aurora R, Milite F, Vander Els NJ. Respiratory emergencies. Semin Oncol 2000;27:256–269

    PubMed  CAS  Google Scholar 

  2. Kanani RS, Drachmann DE. Malignant obstruction of the superior vena cava. N Engl J Med 2006;354:e7

    Article  PubMed  CAS  Google Scholar 

  3. Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database Syst Rev 2001;CD001316

    Google Scholar 

  4. Wilson LD, Detterbeck FC, Yahalom J. Superior vena cava syndrome with malignant causes. N Engl J Med 2007;356:1862–1869

    Article  PubMed  CAS  Google Scholar 

Réf.

  1. Bagley CA, Gokaslan ZL. Cauda equina syndrome caused by primary and metastatic neoplasms. Neurosurg Focus 2004;16:e3

    Article  PubMed  Google Scholar 

  2. Byrne T. Spinal cord compression from epidural metastases. N Engl J Med 1992;327:614–617

    Article  PubMed  CAS  Google Scholar 

  3. Loblaw DA, Laperriere NJ. Emergency treatment of malignant extradural spinal cord compression: an evidence based guideline. J Clin Oncol 1998;16:1613–1624

    PubMed  CAS  Google Scholar 

  4. Maranzano E, Bellavita R, Rossi R et al. Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol 2005;23:3358–3365

    Article  PubMed  Google Scholar 

  5. Quinn JA, DeAngelis LM. Neurologic emergencies in the cancer patient. Semin Oncol 2000;27:311–321

    PubMed  CAS  Google Scholar 

Réf.

  1. Keefe DL. Cardiovascular emergencies in the cancer patient. Semin Oncol 2000;27:244–255

    PubMed  CAS  Google Scholar 

  2. Little WC, Freeman GL. Pericardial disease. Circulation 2006;113:1622–1632

    Article  PubMed  Google Scholar 

  3. Martinoni A, Cipolla CM, Civelli M et al. Intrapericardial treatment of neoplastic pericardial effusions. Herz 2000;25:787–793

    Article  PubMed  CAS  Google Scholar 

  4. Retter AS. Pericardial disease in the oncology patient. Heart Dis 2002;4:387–391

    Article  PubMed  Google Scholar 

  5. Soler-Soler J, Sagrista-Sauleda J, Permanyer-Miralda G. Management of pericardial effusion. Heart 2001;86:235–240

    Article  PubMed  CAS  Google Scholar 

  6. Spodick DH. Acute cardiac tamponade. N Engl J Med 2003;349:684–690

    Article  PubMed  Google Scholar 

Réf.

  1. Bajorunas DR. Clinical manifestations of cancer-related hypercalcemia. Semin Oncol 1990;17:16–20

    PubMed  CAS  Google Scholar 

  2. Flombaum CD. Metabolic emergencies in the cancer patient. Semin Oncol 2000;27:322–334

    PubMed  CAS  Google Scholar 

  3. Perry CM, Figgitt DP. Zoledronic acid. Drugs 2004;64:1197–1211

    Article  PubMed  CAS  Google Scholar 

  4. Stewart AF. Hypercalcemia associated with cancer. N Engl J Med 2005;352:373–379

    Article  PubMed  CAS  Google Scholar 

Réf.

  1. Cairo MS, Bishop M. Tumor lysis syndrome: new therapeutic strategies and classification. Br J Hematol 2004;127:3–11

    Article  Google Scholar 

  2. Del Toro G, Morris E, Cairo MS. Tumor lysis syndrome: pathophysiology, definition and alternative treatment approaches. Clin Adv Hematol Oncol 2005;3:54–61

    PubMed  Google Scholar 

  3. Nicolin G. Emergencies and their management. Eur J Cancer 2002;38:1365–1377

    Article  PubMed  CAS  Google Scholar 

Réf.

  1. British Committee for Standards in Haematology. Guidelines on the management of massive blood loss. Br J Haematol 2006;135:634–641

    Article  Google Scholar 

  2. Imbesi JJ, Kurtz RC. A multidisciplinary approach to gastrointestinal bleeding in cancer patients. J Support Oncol 2005;3:102–110

    Google Scholar 

  3. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007;356:2301–2311

    Article  PubMed  CAS  Google Scholar 

  4. Pereira J, Phan T. Management of bleeding in patients with advanced cancer. Oncologist 2004;9:561–570

    Article  PubMed  Google Scholar 

  5. Reimann T, Butts CA. Upper gastrointestinal bleeding as a metastatic manifestation of breast cancer: a case report and review of the literature. Can J Gastroenterol 2001;15:67–71

    Google Scholar 

Réf.

  1. Davenport DD. Pathophysiology of hemolytic transfusion reactions. Semin Hematol 2005;42:165–169

    Article  PubMed  CAS  Google Scholar 

  2. Dzik WH. New technology for transfusion safety. Br J Haematol 2006;136:181–190

    Article  PubMed  Google Scholar 

  3. Pomper GJ, Wu Y, Snyder EL. Risks of transfusion-transmitted infections 2003. Curr Opin Hematol 2003;10:412–418

    Article  PubMed  Google Scholar 

  4. Popovsky MA (ed). Transfusion Reactions, 2nd edn. AABB Press, Bethesda, USA, 2001

    Google Scholar 

  5. Schroeder ML. Transfusion-associated graft-versus-host disease. Br J Haematol 2002;117:257–287

    Article  Google Scholar 

  6. Sillmann CC, Ambrusi DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005;105:2266–2273

    Article  Google Scholar 

Réf.

  1. Davies AG, Russell WC, Thompson JP. Extravasation and tissue necrosis due to central line infusions. Anaesthesia 2003;58:820–821

    Article  PubMed  CAS  Google Scholar 

  2. Ener RA, Meglathery SB, Styler M. Extravasation of systemic hemato-oncological therapies. Ann Oncol 2004;15:858–862

    Article  PubMed  CAS  Google Scholar 

  3. Goolsby TV, Lombardo FA. Extravasation of chemotherapeutic agents: prevention and treatment. Semin Oncol 2006;33:139–142

    Article  PubMed  CAS  Google Scholar 

  4. Kurul SP, Saip P, Aydin T. Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol 2002;3:684–692

    Article  PubMed  Google Scholar 

  5. Napoli P, Corradino B, Badalamenti G et al. Surgical treatment of extravasation injuries. J Surg Oncol 2005;91:264–268

    Article  PubMed  Google Scholar 

  6. Schrijvers DL. Extravasation: a dreaded complication of chemotherapy. Ann Oncol 2003;14(suppl 3):iii26–30

    PubMed  Google Scholar 

  7. Schulmeister L. Managing vesicant extravasations. Oncologist 2008;13:284–288

    Article  PubMed  Google Scholar 

Download references

Authors
  1. H. Bertz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Henß
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Lubrich
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Bertz, H., Henß, H., Lubrich, B. (2011). Urgences hématologiques et oncologiques. In: Précis d’hématologie et d’oncologie. Springer, Paris. https://doi.org/10.1007/978-2-287-99342-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-99342-8_9

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-99341-1

  • Online ISBN: 978-2-287-99342-8

Publish with us

Policies and ethics

Search

Navigation